Retinal Capillary Vessel Density and Foveal Avascular Zone Size in Patients With Psoriatic Arthritis: A Case-Control Study.
- NCT ID
- NCT07858591
- Registry status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Bursa Yuksek Ihtisas Training and Research Hospital
- Conditions
- Arthritic Psoriasis, Psoriasis (PsO), Retinal Vessels
Overview
ClinicalTrials.gov lists this study as Recruiting.
Official title: Evaluation of Retinal Capillary Vascular Structures and the Foveal Avascular Zone in Patients With Psoriatic Arthritis.
Enrollment: 135 participants (Estimated).
What is being studied
- Diagnostic test: OCTA-DCP
- Diagnostic test: OCTA-FAZ
- Diagnostic test: OCTA-RPC
- Diagnostic test: OCTA-SCP
Who may be eligible
- Ages
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers accepted
- Yes
ClinicalTrials.gov lists the following eligibility criteria.
Study locations
1 study location is listed.
Recruiting site status is explicitly provided for 1 location; 1 is listed as Recruiting.
Countries: Turkey (Türkiye)
- Yıldırım, Turkey (Türkiye): 1
Sample of listed locations
- SBU Bursa Yüksek İhtisas EAH — Bursa, Yıldırım, 16130, Turkey (Türkiye) — Recruiting
Study details
- Start date
- September 1, 2026
- Primary completion date
- August 20, 2027
- Completion date
- August 31, 2027
- First posted
- October 5, 2026
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT07858591
- Registry last updated
- October 5, 2026
- QualifiedStudies registry data refreshed
- October 12, 2026
- QualifiedStudies record fetched
- October 12, 2026
View NCT07858591 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | Arthritis studies | Clinical trial FAQ